AAPCHO Statement on FDA Approval of the Comirnaty Vaccine
August 24, 2021
FOR IMMEDIATE RELEASE
WASHINGTON— The Association of Asian Pacific Community Health Organizations (AAPCHO) today released the following statement applauding the U.S. Food and Drug Administration approval of the Comirnaty vaccine.
Comirnaty vaccine, formerly known as the Pfizer-BioNTech COVID-19 vaccine, was approved and is found to be 91% effective in preventing COVID-19 disease.
Jeffrey B. Caballero, executive director of AAPCHO, said:
“AAPCHO commends the scientists, researchers, and patients for their efforts, including rigorous research, safety testing, and data tracking, to approve the Comirnaty vaccine. While cases of COVID-19 are steadily rising across the United States again, we encourage all members of our community to continue seeking and promoting accurate information about COVID-19 and vaccines from reputable sources, like our member health centers and trusted community partners.
“AAPCHO remains committed to supporting health centers and community-based organizations to equitably vaccinate vulnerable populations disproportionately affected by the COVID-19 pandemic, including Asian, Asian American, Native Hawaiian, and Pacific Islander communities.”
If you and your loved ones need a COVID-19 vaccine, visit vaccines.gov or call 1-800-232-0233 to find an appointment near you today.
For additional in-language resources and information, AAPCHO’s COVID-19 Resource Hub.
AAPCHO is a national association of community health organizations dedicated to promoting advocacy, collaboration and leadership that improves the health status and access of Asian Americans, Native Hawaiians, and Pacific Islanders in the United States, the U.S. territories, and Freely Associated States. For more information on AAPCHO, please visit www.aapcho.org.
Kristine Cecile Alarcon, MPH, (510) 671-5054, firstname.lastname@example.org